Literature DB >> 19001599

Overexpression of OLC1, cigarette smoke, and human lung tumorigenesis.

Jingsong Yuan1, Jinfang Ma, Hongwei Zheng, Taiping Shi, Wenyue Sun, Qiao Zhang, Dongmei Lin, Kaitai Zhang, Jie He, Yousheng Mao, Xia Gao, Peng Gao, Naijun Han, Guobin Fu, Ting Xiao, Yanning Gao, Dalong Ma, Shujun Cheng.   

Abstract

BACKGROUND: Exposure to cigarette smoke is a major risk factor for lung cancer, but how it induces cancer is unclear. The overexpressed in lung cancer 1 (OLC1) gene is one of 50 candidate lung cancer genes identified by suppression subtractive hybridization as having higher expression in squamous cell carcinoma (SCC) than normal lung epithelia.
METHODS: We used immunohistochemistry (IHC) to measure OLC1 protein levels in primary lung cancer samples from 559 patients and used fluorescence in situ hybridization to measure OLC1 copy number in primary SCC samples from 23 patients. We compared OLC1 protein expression in SCC samples of 371 patients with and without a smoking history using the Pearson chi(2) test. We assayed OLC1 protein levels by immunoblotting in H1299 human lung cancer cells, immortalized human bronchial epithelial cells, and primary cultured normal human bronchial epithelial cells that were treated with cigarette smoke condensate. We assayed tumor formation in athymic mice using NIH3T3 mouse fibroblast cells transfected with OLC1 (eight mice) and analyzed apoptosis and colony formation of H1299 and H520 lung cancer cells transfected with scrambled (negative) or OLC1 small interfering RNAs (siRNAs) (s1).
RESULTS: OLC1 protein was overexpressed in 387 of 464 (83.4%) of primary lung cancers, as detected by IHC, and OLC1 was amplified in 14 of 23 (60%) of SCC samples. OLC1 protein overexpression was more common in SCC patients with a smoking history than those without (77.1% vs 45.8%, P < .001). In addition, cigarette smoke condensate increased OLC1 protein levels in H1299 cells, immortalized human bronchial epithelial cells, and primary cultured normal human bronchial epithelial cells. Overexpression of OLC1 induced tumor formation in athymic mice (control vs OLC1, 0% vs 100%). Knockdown of OLC1 increased apoptosis (mean percentage of apoptotic H1299 cells, s1 vs negative: 30.3% vs 6.4%, difference = 23.9%, 95% confidence interval [CI] = 19.1% to 28.5%, P = .002; mean percentage of apoptotic H520 cells, s1 vs negative: 21.6% vs 4.9%, difference = 16.7%, 95% CI = 10.6% to 22.8%, P = .007) and decreased colony formation (mean no. of colonies of H1299 cells transfected with siRNAs, negative vs s1: 84 vs 4, difference = 80, 95% CI = 71 to 88, P < .001; mean no. of colonies of H520 cells transfected with siRNAs, negative vs s1: 103 vs 24, difference = 79, 95% CI = 40 to 116, P = .005).
CONCLUSIONS: OLC1 is a candidate oncogene in lung cancer whose expression may be regulated by exposure to cigarette smoke.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001599      PMCID: PMC3299210          DOI: 10.1093/jnci/djn379

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  40 in total

Review 1.  The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder.

Authors:  D Hoffmann; I Hoffmann; K El-Bayoumy
Journal:  Chem Res Toxicol       Date:  2001-07       Impact factor: 3.739

2.  The international system for staging lung cancer.

Authors:  C F Mountain
Journal:  Semin Surg Oncol       Date:  2000-03

Review 3.  Focus on lung cancer.

Authors:  John D Minna; Jack A Roth; Adi F Gazdar
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

4.  Molecular characteristics of non-small cell lung cancer.

Authors:  M Nacht; T Dracheva; Y Gao; T Fujii; Y Chen; A Player; V Akmaev; B Cook; M Dufault; M Zhang; W Zhang; M Guo; J Curran; S Han; D Sidransky; K Buetow; S L Madden; J Jen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 5.  Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.

Authors:  F R Hirsch; W A Franklin; A F Gazdar; P A Bunn
Journal:  Clin Cancer Res       Date:  2001-01       Impact factor: 12.531

6.  Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis.

Authors:  Chaitanya S Bangur; Ann Switzer; Liqun Fan; Matthew J Marton; Michael R Meyer; Tongtong Wang
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

7.  Cancer statistics, 2001.

Authors:  R T Greenlee; M B Hill-Harmon; T Murray; M Thun
Journal:  CA Cancer J Clin       Date:  2001 Jan-Feb       Impact factor: 508.702

8.  Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells.

Authors:  D W Kim; M A Sovak; G Zanieski; G Nonet; R Romieu-Mourez; A W Lau; L J Hafer; P Yaswen; M Stampfer; A E Rogers; J Russo; G E Sonenshein
Journal:  Carcinogenesis       Date:  2000-05       Impact factor: 4.944

9.  Inhibition of constitutive NF-kappa B activity suppresses tumorigenicity of Ewing sarcoma EW7 cells.

Authors:  Delphine Javelaud; Marie-France Poupon; Juana Wietzerbin; Françoise Besançon
Journal:  Int J Cancer       Date:  2002-03-10       Impact factor: 7.396

10.  Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.

Authors:  N Y Hsu; H C Ho; K C Chow; T Y Lin; C S Shih; L S Wang; C M Tsai
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

View more
  12 in total

1.  Defining a candidate lung cancer gene.

Authors:  Frederic J Kaye
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

2.  Vam3, a derivative of resveratrol, attenuates cigarette smoke-induced autophagy.

Authors:  Ji Shi; Ning Yin; Ling-ling Xuan; Chun-suo Yao; Ai-min Meng; Qi Hou
Journal:  Acta Pharmacol Sin       Date:  2012-06-18       Impact factor: 6.150

Review 3.  Regulation of Vps4 during MVB sorting and cytokinesis.

Authors:  Markus Babst; Brian A Davies; David J Katzmann
Journal:  Traffic       Date:  2011-07-07       Impact factor: 6.215

4.  Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer.

Authors:  Yi-Wei Wang; Pang-Hsien Tu; Kuen-Tyng Lin; Shu-Chen Lin; Jenq-Yuh Ko; Yuh-Shan Jou
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

5.  Role of E3 ubiquitin ligases in lung cancer.

Authors:  Barbara C Snoek; Leonie Ham de Wilt; Gerrit Jansen; Godefridus J Peters
Journal:  World J Clin Oncol       Date:  2013-08-10

6.  OLC1 is overexpressed in breast cancer and its expression correlates with poor patient survival.

Authors:  Qiao-Hong Ou-Yang; Zhong-Xiang Duan; Zheng Jin; Ji-Xiao Lei
Journal:  Tumour Biol       Date:  2014-06-01

7.  Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma.

Authors:  Xiao Li; Jing Suo; Shujuan Shao; Liyan Xue; Wei Chen; Lijia Dong; Ji Shi; Ming Fu; Ning Lu; Qimin Zhan; Tong Tong
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

8.  Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.

Authors:  Jue Wang; Hongchang Shen; Guobin Fu; Dandan Zhao; Weibo Wang
Journal:  Oncotarget       Date:  2017-02-07

9.  [Overexpression of OLC1 in Lung Squamous Cell Carcinoma Tissues is Associated with Poor Prognosis of Patients].

Authors:  Kunpeng Zhang; Gefei Zhao; Ting Xiao; Ping Li; Jie Song; Yanning Gao; Kelin Sun
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-05-20

10.  Decreased expression of 14-3-3 σ, an early event of malignant transformation of respiratory epithelium, also facilitates progression of squamous cell lung cancer.

Authors:  Nan Sun; Yongkai Wu; Bo Huang; Qian Liu; Yinan Dong; Jianqiao Ding; Yongyu Liu
Journal:  Thorac Cancer       Date:  2015-03-18       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.